Cargando…
Secondary Cutaneous Mucormycosis Post-COVID-19: Case Series from a Tertiary Center
BACKGROUND: Mucormycosis is an angioinvasive mucorales fungal infection. Cutaneous type formed 10.5% of cases in India in precovid-19 era. Glucocorticoid-induced immunosuppression and hyperglycemia, reusable oxygen humidifiers in COVID-19 therapy, and preexisting uncontrolled diabetes mellitus contr...
Autores principales: | Abhirami, B, Kumar, Prabhat, Mishra, Dharmendra Kumar, Yadav, Satyendra Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455132/ https://www.ncbi.nlm.nih.gov/pubmed/36092197 http://dx.doi.org/10.4103/ijd.ijd_781_21 |
Ejemplares similares
-
Secondary Cutaneous Mucormycosis – Retrospective Analysis From Tertiary Care Hospitall
por: Arora, Nikhil, et al.
Publicado: (2023) -
Management of post-COVID mucormycosis at a tertiary care center in Northern India
por: Pathak, Lav, et al.
Publicado: (2023) -
Cutaneous adverse drug reaction profile in a tertiary care out patient setting in Eastern India
por: Saha, Abanti, et al.
Publicado: (2012) -
Mucormycosis in COVID-19 pandemic: Risk factors and linkages
por: Kumar, Manoj, et al.
Publicado: (2021) -
Yoga Practice Improves the Body Mass Index and Blood Pressure: A Randomized Controlled Trial
por: Chauhan, Ashutosh, et al.
Publicado: (2017)